Dupilumab in Patients with Eosinophilic Esophagitis. Reply
N Engl J Med
.
2023 Mar 9;388(10):956-957.
doi: 10.1056/NEJMc2300703.
Authors
Evan S Dellon
1
,
Marc E Rothenberg
2
,
Albert J Bredenoord
3
Affiliations
1
University of North Carolina School of Medicine, Chapel Hill, NC evan_dellon@med.unc.edu.
2
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
3
Amsterdam University Medical Center, Amsterdam, the Netherlands.
PMID:
36884333
DOI:
10.1056/NEJMc2300703
No abstract available
Publication types
Letter
Comment
MeSH terms
Adolescent
Adult
Antibodies, Monoclonal, Humanized / therapeutic use
Eosinophilic Esophagitis* / drug therapy
Gastritis*
Humans
Substances
dupilumab
Antibodies, Monoclonal, Humanized
Supplementary concepts
Eosinophilic enteropathy